Valproate monotherapy in juvenile myoclonic epilepsy: Dose-related effects on electroencephalographic and other neurophysiologic tests

Therapeutic Drug Monitoring

Volumn 21, Issue 1, 1999, Pages 91-96

  Sundqvist, Anders ^a   Nilsson, Bengt Y ^b   Tomson, Torbjörn ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b STOCKHOLM SÖDER HOSPITAL   (Sweden)

Author keywords

Critical flicker fusion; Electroencephologram; Epilepsy; Monotherapy; Sleep; Valproic acid; Visual contrast sensitivity; Visual evoked potentials

Indexed keywords

VALPROIC ACID;

ADOLESCENT; ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICAL FLICKER FUSION; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG MONITORING; ELECTROENCEPHALOGRAM; EVOKED VISUAL RESPONSE; FEMALE; HUMAN; MALE; MYOCLONUS EPILEPSY; NEUROPHYSIOLOGY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SLEEP;

ADOLESCENT; ADULT; ANTICONVULSANTS; CONTRAST SENSITIVITY; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; ELECTROENCEPHALOGRAPHY; EPILEPSIES, MYOCLONIC; EVOKED POTENTIALS, VISUAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPHYSIOLOGY; OUTCOME ASSESSMENT (HEALTH CARE); VALPROIC ACID;

EID: 0033023265     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-199902000-00014     Document Type: Article

References (25)

1. Sundqvist A, Tomson T, Lundkvist B. Pharmacokinetics of valproic acid in patients with juvenile myoclonic epilepsy on monotherapy. Ther Drug Monit 1997:19:153-9.
2. Sundqvist A, Tomson T, Lundkvist B. Valproate as monotherapy for juvenile myoclonic epilepsy: Dose-effect study. Ther Drug Monit 1998;20:149-57.
3. Carskadon MA, Dement WC, Miller MM, Roth T, Westbrook PR, Keenan S. Guidelines for the multiple sleep latency test (MSLT): a standard measure of sleepiness. Sleep 1986;9:519-24.
4. Tomson T, Nilsson BY, Levi R. Impaired visual contrast sensitivity in epileptic patients treated with carbamazepine. Arch Neurol 1988;45:897-900.
5. Furuskog P, Nilsson BY. Contrast sensitivity in patients with posterior chamber intraocular lens implants. Acta Opthalmol 1988;66: 438-44.
6. Morris JA, Gardiner MJ. Calculating confidence intervals for relative risks (odds ratios) and standardised ratios and rates. Br Med J 1988;296:1313-6.
7. Villareal HJ, Wilder BJ, Willmore LJ, Baumann AW, Hammond EJ, Bruni J. Effects of valproic acid on spike and wave discharges in patients with absence seizures. Neurology 1978;28:886-91.
8. Braathen G, Theorell K, Persson A, Rane A. Valproate in the treatment of absence epilepsy in children: A study of dose-response relationships. Epilepsia 1988;29:548-52.
9. Bruni J, Wilder BJ, Baumann AW, Willmore LJ. Clinical efficacy and long-term effects of valproic acid therapy on spike-wave discharges. Neurology 1980;30:42-6.
10. Gallassi R, Morreale A, Lorusso S, Procaccianti G, Lugaresi E, Baruzzi A. Cognitive effects of valproate. Epilepsy Res 1990;5: 160-4.
11. Asconapé J, Kiffin Penry J. Some clinical and EEG aspects of benign juvenile myoclonic epilepsy. Epilepsia 1984;25:108-14.
12. Janz D. Epilepsy with impulsive petit mal (juvenile myoclonic epilepsy). Acta Neurol Scand 1985;72:449-59.
13. Mayr N, Zeitlhofer J, Feucht M, Deecke L. Die Variabilität der Anzahl und tageszeitlichen Verteilung von Spike wave Paroxysmen in zwei kurz aufeinanderfogenden 24-Stunden-EEG-Langzeitableitungen. Z EEG-EMG 1989;20:185-8.
14. Miller H, Blume WT. Primary generalized seizure disorder: correlation of epilepliform discharges with seizure frequency. Epilepsia 1993;34:128-32.
15. Pedersen B, Juul-Jensen P. Electroencephalographic alterations during intoxication with sodium valproate: a case report. Epilepsia 1984;25:121-4.
16. Benninger C, Matthis P, Scheffner D. Spectral analysis of the EEG in children during the introduction of antiepileptic therapy with valproic acid. Neuropsychobiology 1985;13:93-6.
17. Lancman ME, Asconapé J, Penry JK. Clinical and EEG asymmetries in juvenile myoclonic epilepsy. Epilepsia 1994;35:302-6.
18. Genton P, Del Socorro Gonzalez Sanchez M, Saltarelli A, Bureau M, Dravet C, Roger J. électroencéphalogramme standard et ses aspects trompeurs dans l'épilepsie myoclonique juvénile: étude rétrospective de 56 cas consécutifs. Neurophysiol Clin 1995;25: 283-90.
19. Manni R, Ratti MT, Perucca E, Galimberti CA, Tartara A. A multiparametric investigation of daytime sleepiness and psychomotor functions in epileptic patients treated with phenobarbital and sodium valproate: a comparative controlled study. Electroencephalogr Clin Neurophysiol 1993;86:322-8.
20. Mervaala E, Keränen T, Penttilä M, Partanen JV, Riekkinen P. Pattern-reversal VEP and cortical SEP latency prolongations in epilepsy. Epilepsia 1985:26:441-5.
21. Harding GFA, Alford CA, Powell TE. The effect of sodium valproate on sleep, reaction times, and visual evoked potential in normal subjects. Epilepsia 1985;26:597-601.
22. Bodis-Wollner I, Diamond SP. The measurement of spatial contrast sensitivity in cases of blurred vision associated with cerebral lesions. Brain 1976;99:695-710.
23. MacPhee GJ, Goldie C, Roulston D, et al. Effect of carbamazepine on pshychomotor performance in naive subjects. Eur J Clin Pharmacol 1986;30:37-12.
24. Smith DB, Mattson RH, Cramer JA, et al. Results of a nationwide Veterans Administration cooperative study comparing the efficacy and toxicity of carbamazepine, phenobarbital, phenytoin, and primidone. Epilepsia 1987;28(suppl 3):S50-8.
25. MacPhee GJ, Mitchell JR, Wiseman L, et al. Effect of sodium valproate and carbamazepine disposition and psychomotor profile in man. Br J Clin Pharmacol 1988;25:59-66.